Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial
50 auth. L. Heaney, J. Busby, C. Hanratty, R. Djukanović, A. Woodcock, S. Walker, T. Hardman, J. Arron, D. Choy, P. Bradding, C. Brightling, R. Chaudhuri, D. Cowan, A. Mansur, S. Fowler, ... R. Niven, P. Howarth, J. Lordan, A. Menzies-Gow, T. Harrison, D. Robinson, C. Holweg, J. Matthews, I. Pavord, I. Adcock, A. Azim, M. Bellamy, C. Borg, M. Bourne, C. Connolly, R. Costello, C. Corrigan, Sarah E. Davies, G. Davies, K. Chung, Gabrielle Gainsborough, T. Grandison, B. Hargadon, Avril Horn, V. Hudson, D. Jackson, S. Johnston, G. Jones, Paula McCourt, María Nuñez, D. Shaw, Katherine Smith, Joel Solis, R. Stone, Freda Yang